Sagimet Biosciences, Inc. Class A (SGMT) Stock Statistics & Valuation Metrics

Sagimet Biosciences, Inc. Class A has a market cap or net worth of $645.49M. The enterprise value is $172.39.

Sagimet Biosciences, Inc. Class A has 61,184,315 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -51.04%.

The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is -0.42.

In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -51.04M in profits. Earnings per share was -1.58.

In the last 12 months, operating cash flow was -41.32M and capital expenditures 0.00, giving a free cash flow of -41.32M billion.

Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Sagimet Biosciences, Inc. Class A upcoming earnings date is Nov 12, 2026, After Close (Confirmed).

Sagimet Biosciences, Inc. Class A as a current ratio of 22.82, with Debt / Equity ratio of 0.76%

In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.

Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -3.07, with an EV/FCF ratio of -3.43.

Sagimet Biosciences, Inc. Class A has $240.13M in cash and marketable securities with $1.94M in debt, giving a net cash position of $238.19M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sagimet Biosciences, Inc. Class A is $29.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy